Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sidney Keisner

Concepts (49)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bone Density Conservation Agents
2
2023
74
0.890
Why?
Bone Neoplasms
2
2023
179
0.810
Why?
Phenylthiohydantoin
1
2016
2
0.540
Why?
Warfarin
1
2016
83
0.500
Why?
Anticoagulants
1
2016
254
0.430
Why?
Thrombosis
1
2016
249
0.430
Why?
Ketoconazole
1
2010
17
0.360
Why?
Androgen Antagonists
1
2010
11
0.360
Why?
Carcinoma, Renal Cell
1
2011
101
0.340
Why?
Sulfonamides
1
2011
125
0.340
Why?
Proton Pump Inhibitors
1
2010
85
0.340
Why?
Pyrimidines
1
2011
193
0.330
Why?
Kidney Neoplasms
1
2011
174
0.330
Why?
Protein Kinase Inhibitors
1
2011
205
0.320
Why?
Antineoplastic Agents
1
2016
1178
0.300
Why?
Prostatic Neoplasms
1
2010
394
0.270
Why?
Drug Interactions
2
2016
208
0.210
Why?
Phthalazines
1
2022
20
0.200
Why?
Piperazines
1
2022
118
0.180
Why?
Indoles
1
2022
273
0.160
Why?
Retrospective Studies
3
2023
6223
0.140
Why?
Prospective Studies
1
2023
2414
0.140
Why?
Nitriles
1
2016
52
0.130
Why?
Benzamides
1
2016
51
0.130
Why?
Humans
6
2023
50389
0.130
Why?
Male
4
2022
25718
0.110
Why?
Controlled Clinical Trials as Topic
1
2011
21
0.090
Why?
Clinical Trials, Phase III as Topic
1
2011
43
0.090
Why?
Indazoles
1
2011
44
0.090
Why?
Prostate-Specific Antigen
1
2010
47
0.090
Why?
Drug Resistance
1
2010
64
0.090
Why?
Treatment Outcome
2
2011
5230
0.090
Why?
Diphosphonates
1
2011
90
0.090
Why?
Imidazoles
1
2011
128
0.080
Why?
Middle Aged
3
2016
12460
0.080
Why?
Disease-Free Survival
1
2010
450
0.080
Why?
Gastrointestinal Diseases
1
2010
128
0.080
Why?
Drug Therapy, Combination
1
2010
383
0.080
Why?
Acute Kidney Injury
1
2011
295
0.070
Why?
Aged, 80 and over
2
2011
3180
0.070
Why?
Aged
2
2011
9590
0.040
Why?
Animals
1
2011
13173
0.030
Why?
Creatinine
1
2011
144
0.020
Why?
Incidence
1
2011
1017
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1356
0.020
Why?
Time Factors
1
2011
2934
0.010
Why?
Neoplasms
1
2011
1237
0.010
Why?
Adult
1
2011
13568
0.010
Why?
Female
1
2011
26981
0.010
Why?
Keisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description